The Mycobactin Biosynthesis Pathway: A Prospective Therapeutic Target in the Battle against Tuberculosis

Author:

Shyam Mousumi12ORCID,Shilkar Deepak1ORCID,Verma Harshita2ORCID,Dev Abhimanyu1,Sinha Barij Nayan1,Brucoli Federico3ORCID,Bhakta Sanjib2,Jayaprakash Venkatesan1ORCID

Affiliation:

1. Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi 835215 Jharkhand, India

2. Mycobacteria Research Laboratory, Department of Biological Sciences, Institute of Structural and Molecular Biology, Birkbeck, University of London, Malet Street, London WC1E 7HX, U.K.

3. Leicester School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9BH, U.K.

Funder

Science and Engineering Research Board

British Council - Newton Bhabha Fund

Global Challenges Research Fund

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Reference162 articles.

1. World Health Organization. Global Task Force on TB Impact Measurement; WHO: 2019. https://www.who.int/tb/areas-of-work/monitoring-evaluation/impact_measurement_taskforce/en/ (accessed Nov 7, 2019).

2. History of Tuberculosis

3. The tuberculosis pandemic: implications for health in the tropics

4. Foamy macrophages and the progression of the human tuberculosis granuloma

5. WHO global progress report on tuberculosis elimination

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3